TECH Bio-Techne Corporation

72.70USD-0.07%Mkt Cap: 11.42B USDP/E: 66.70

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates t…

Institutional holders20 on file

Key Statistics

Company
Market Cap11.42B USD
Enterprise Value11.36B USD
Revenue (TTM)1.23B USD
Gross Profit799.07M USD
Net Income (TTM)181.86M USD
Revenue/Share7.86 USD
Last Price72.70 USD
Fiscal Year EndJun 2026
MR QuarterSep 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)66.70
P/E (Forward)31.44
PEG2.17
EV/EBITDA34.92
EV/Revenue9.25
P/S9.30
P/B5.27
EPS (TTM)1.09 USD
EPS (Forward)2.31 USD
52W Range
43.2099% of range72.88
52W High72.88 USD
52W Low43.20 USD
Profitability
Gross Margin65.77%
Oper. Margin21.69%
EBITDA Margin26.49%
Profit Margin14.97%
ROE8.63%
ROA7.03%
ROIC9.66%
ROCE11.25%
Growth
Revenue Growth4.60%
Earnings Growth-25.00%
Cash Flow & Leverage
Operating CF292.07M USD
CapEx (TTM)28.85M USD
FCF Margin22.62%
FCF Yield2.43%
Net Debt-65.57M USD
Net Debt/EBITDA-0.20
Net Debt/FCF-0.24
Balance Sheet
Debt/Equity0.14
Current Ratio2.28
Quick Ratio1.53
Book Value/Sh13.79 USD
Cash/Share2.23 USD
Dividends
Fwd Div Rate0.32 USD
Trail. Div Rate0.24 USD
Div. Yield0.44%
5Y Avg Yield0.43%
Payout Ratio29.36%
Ex-Div DateNov 13, 2026
Pay DateNov 23, 2026
Splits
Last Split4:1
Split DateNov 30, 2022
Analyst Consensus
Rating3.2 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)70.50 USD
Upside (mean)-3.0%
Target Range50.00 USD – 73.00 USD
50.00-3.0% to mean73.00
# Analysts10
Ownership
Shares Out.157.09M
Float156.39M
Insiders0.40%
Institutions98.97%
Short Interest
Short Ratio2.8d
Short % Float4.92%
Short % Out.4.91%
Shares Short7.70M
Short (prev mo.)7.39M
Technical
SMA 5072.54 (+0.2%)
SMA 20063.42 (+14.6%)
Beta1.27
S&P 52W Chg12.08%
Avg Vol (30d)2.87M
Avg Vol (10d)3.27M
Technical Indicators
RSI (14)52.5
MACD0.0683
MACD Signal0.0908
MACD Hist.-0.0226
BB Upper72.88 USD
BB Middle72.72 USD
BB Lower72.56 USD
BB Width0.45%
ATR (14)0.1336 USD
Vol Ratio (20d)1.11x

About Bio-Techne (NASDAQ: TECH)

›

Bio-Techne (NASDAQ: TECH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 3,000 employees.

The shares were at 72.70 USD on 19 November 2026, up 21.8% over 52 weeks. Its 52-week range is 43.20 USD to 72.88 USD, and it trades at the top of that range.

At a market capitalisation of 11.42B USD, it trades at 66.7 times trailing earnings and 31.4 times forward earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.5, a premium of 99% for TECH. It pays a dividend yielding 0.44% (it pays out 29% of its earnings), against a median of 0.94% among the dividend payers in that peer group.

Bio-Techne reports return on equity of 8.6%, an operating margin of 21.7% and revenue up 4.6% year over year.

It holds more cash than debt, a net cash position of 65.57M USD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 10 analysts cover the stock, with an average rating of Hold; their mean price target of 70.50 USD is 3.0% below the current price. The next earnings report is expected on 9 February 2027.